Christos Tikellis

Title: Christos Tikellis: Innovator in RAGE Modulation

Introduction

Christos Tikellis is an accomplished inventor based in Oakleigh, Australia. He has made significant contributions to the field of biochemistry, particularly in the modulation of the Receptor for Advanced Glycation End-products (RAGE). His innovative work has implications for understanding various biological processes and potential therapeutic applications.

Latest Patents

Christos Tikellis holds a patent for a method of screening candidate agents that can modulate RAGE activity. The patent, titled "Screening assays, modulators and modulation of activation of Receptor for Advanced Glycation End-products (RAGE)," outlines a method that involves contacting a RAGE polypeptide with a GPCR polypeptide in the presence of a candidate agent. This method aims to detect whether the candidate agent can modulate RAGE activation induced by an active co-located GPCR.

Career Highlights

Throughout his career, Christos has worked with prestigious institutions, including Beijing University of Technology and The University of Western Australia. His research has focused on the intricate mechanisms of receptor activation and the potential for therapeutic interventions in related diseases.

Collaborations

Christos has collaborated with notable professionals in his field, including Kevin Donald George Pfleger and Merlin Christopher Thomas. These collaborations have enriched his research and contributed to advancements in understanding RAGE modulation.

Conclusion

Christos Tikellis is a prominent figure in the field of biochemistry, with a focus on RAGE modulation. His innovative patent and collaborations highlight his commitment to advancing scientific knowledge and potential therapeutic applications.